Federal Register / Vol. 72, No.

221 / Friday, November 16, 2007 / Notices 64683

Rhodes Technologies to manufacture Pennsville, New Jersey 08070, made
the listed basic classes of controlled application by renewal to the Drug
substances is consistent with the public Enforcement Administration (DEA) to
interest at this time. DEA has be registered as a bulk manufacturer of
investigated Rhodes Technologies to the basic classes of controlled
ensure that the company’s registration is substances listed in schedule I and II:
consistent with the public interest. The
investigation has included inspection Drug
and testing of the company’s physical
Dihydromorphine (9145) ...............
security systems, verification of the
Amphetamine (1100) ....................
company’s compliance with state and Methylphenidate (1724) ................
local laws, and a review of the Amobarbital (2125) .......................
company’s background and history. Pentobarbital (2270) .....................
Therefore, pursuant to 21 U.S.C. 823, Secobarbital (2315) ......................
and in accordance with 21 CFR 1301.33, Glutethimide (2550) ......................
Codeine (9050) .............................
the above named company is granted
registration as a bulk manufacturer of Oxycodone (9143) ........................
Hydromorphone (9150) ................
the basic classes of controlled Hydrocodone (9193) .....................
substances listed. Methadone (9250) ........................
Dated: November 5, 2007. Methadone intermediate (9254) ...
Joseph T. Rannazzisi, Dextropropoxyphene, bulk (non-
dosage forms) (9273).
Deputy Assistant Administrator, Office of
Morphine (9300) ...........................
Diversion Control, Drug Enforcement Oxymorphone (9652) ...................
Administration.
[FR Doc. E7–22487 Filed 11–15–07; 8:45 am] The company plans to manufacture
BILLING CODE 4410–09–P the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
DEPARTMENT OF JUSTICE received. DEA has considered the
factors in 21 U.S.C. 823(a) and
Drug Enforcement Administration determined that the registration of
Manufacturer of Controlled Siegfried (USA), Inc. to manufacture the
Substances; Notice of Registration listed basic classes of controlled
substances is consistent with the public
By Notice dated June 26, 2007, and interest at this time. DEA has
published in the Federal Register on investigated Siegfried (USA), Inc. to
July 5, 2007, (72 FR 36730), Siegfried ensure that the company’s registration is
(USA), Inc., Industrial Park Road, consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
Schedule and in accordance with 21 CFR 1301.33,
the above named company is granted
I
registration as a bulk manufacturer of
II
II the basic classes of controlled
II substances listed.
II Dated: November 5, 2007.
II
Joseph T. Rannazzisi,
II
II Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
II
II Administration.
II [FR Doc. E7–22493 Filed 11–15–07; 8:45 am]
II BILLING CODE 4410–09–P
II
II
DEPARTMENT OF JUSTICE
II
II
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 26, 2007, and
published in the Federal Register on
July 5, 2007, (72 FR 36730–36731),
Sigma Aldrich Research Biochemicals,
Inc., 1–3 Strathmore Road, Natick,
Massachusetts 01760, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:

Drug Schedule

Cathinone (1235) ......................................................................................................................................................................................... I

Methcathinone (1237) .................................................................................................................................................................................. I
Aminorex (1585) .......................................................................................................................................................................................... I
Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I
Lysergic acid diethylamide (7315) ............................................................................................................................................................... I
Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I
4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I
4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I
3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I
3,4-Methylenedioxymethamphetamine (MDMA) (7405) .............................................................................................................................. I
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) (7470) ..................................................................................................................................... I
1-Benzylpiperazine (BZP) (7493) ................................................................................................................................................................ I
Heroin (9200) ............................................................................................................................................................................................... I
Normorphine (9313) .................................................................................................................................................................................... I
Amphetamine (1100) ................................................................................................................................................................................... II
Methamphetamine (1105) ........................................................................................................................................................................... II
Nabilone (7379) ........................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
Cocaine (9041) ............................................................................................................................................................................................ II
Codeine (9050) ............................................................................................................................................................................................ II
mstockstill on PROD1PC66 with NOTICES

Diprenorphine (9058) ................................................................................................................................................................................... II

Ecgonine (9180) .......................................................................................................................................................................................... II
Levomethorphan (9210) .............................................................................................................................................................................. II
Levorphanol (9220) ..................................................................................................................................................................................... II
Meperidine (9230) ....................................................................................................................................................................................... II
Metazocine (9240) ....................................................................................................................................................................................... II

VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1
 64684 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices

Drug Schedule

Methadone (9250) ....................................................................................................................................................................................... II

Morphine (9300) .......................................................................................................................................................................................... II
Thebaine (9333) .......................................................................................................................................................................................... II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Carfentanil (9743) ........................................................................................................................................................................................ II
Fentanyl (9801) ........................................................................................................................................................................................... II

The company plans to manufacture No comments or objections have been Administration (DEA) to be registered as
reference standards. received. DEA has considered the an importer of the basic classes of
No comments or objections have been factors in 21 U.S.C. 823(a) and 952(a) controlled substances listed in schedule
received. DEA has considered the and determined that the registration of I:
factors in 21 U.S.C. 823(a) and Stepan Company to import the basic
determined that the registration of class of controlled substance is Drug Schedule
Sigma Aldrich Research Biochemicals, consistent with the public interest and
with United States obligations under Marihuana (7360) ......................... I
Inc. to manufacture the listed basic class
international treaties, conventions, or Tetrahydrocannabinols (7370) ..... I
of controlled substance is consistent
with the public interest at this time. protocols in effect on May 1, 1971, at
DEA has investigated Sigma Aldrich this time. DEA has investigated Stepan The company plans to import the
Research Biochemicals, Inc. to ensure Company to ensure that the company’s above listed synthetic products for non-
that the company’s registration is registration is consistent with the public clinical laboratory based research only.
consistent with the public interest. The interest. The investigation has included
inspection and testing of the company’s Any bulk manufacturer who is
investigation has included inspection presently, or is applying to be,
and testing of the company’s physical physical security systems, verification
of the company’s compliance with state registered with DEA to manufacture
security systems, verification of the such basic classes of controlled
company’s compliance with state and and local laws, and a review of the
company’s background and history. substances may file comments or
local laws, and a review of the objections to the issuance of the
company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21 proposed registration and may, at the
Therefore, pursuant to 21 U.S.C. 823,
CFR 1301.34, the above named company same time, file a written request for a
and in accordance with 21 CFR 1301.33,
is granted registration as an importer of hearing on such application pursuant to
the above named company is granted
registration as a bulk manufacturer of the basic class of controlled substance 21 CFR 1301.43 and in such form as
the basic classes of controlled listed. prescribed by 21 CFR 1316.47.
substances listed. Dated: November 6, 2007. Any such comments or objections
Dated: November 5, 2007. Joseph T. Rannazzisi, being sent via regular mail should be
Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of addressed, in quintuplicate, to the Drug
Diversion Control, Drug Enforcement Enforcement Administration, Office of
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration. Diversion Control, Federal Register
Administration. [FR Doc. E7–22507 Filed 11–15–07; 8:45 am] Representative (ODL), Washington, DC
[FR Doc. E7–22497 Filed 11–15–07; 8:45 am] BILLING CODE 4410–09–P 20537, or any being sent via express
BILLING CODE 4410–09–P
mail should be sent to Drug
Enforcement Administration, Office of
DEPARTMENT OF JUSTICE Diversion Control, Federal Register
DEPARTMENT OF JUSTICE Representative (ODL), 2401 8701
Drug Enforcement Administration Morrissette Drive, Springfield, Virginia
Drug Enforcement Administration 22152; and must be filed no later than
Importer of Controlled Substances;
Notice of Application December 17, 2007.
Importer of Controlled Substances;
Notice of Registration This procedure is to be conducted
Pursuant to 21 U.S.C. 958(i), the
simultaneously with, and independent
Attorney General shall, prior to issuing
By Notice dated April 17, 2007 and of, the procedures described in 21 CFR
a registration under this Section to a
published in the Federal Register on 1301.34(b), (c), (d), (e) and (f). As noted
bulk manufacturer of a controlled
April 30, 2007, (72 FR 21298–21299), in a previous notice published in the
substance in schedule I or II and prior
Stepan Company, Natural Products to issuing a registration under 21 U.S.C. Federal Register on September 23, 1975,
Department, 100 W. Hunter Avenue, 952(a)(2) authorizing the importation of (40 FR 43745–46), all applicants for
Maywood, New Jersey 07607, made such a substance, provide registration to import a basic class of
application by renewal to the Drug manufacturers holding registrations for any controlled substances in schedule I
Enforcement Administration (DEA) to the bulk manufacture of the substance or II are and will continue to be required
be registered as an importer of Coca an opportunity for a hearing. to demonstrate to the Deputy Assistant
Leaves (9040), a basic class of controlled Therefore, in accordance with Title 21 Administrator, Office of Diversion
mstockstill on PROD1PC66 with NOTICES

substance listed in schedule II. Code of Federal Regulations (CFR), Control, Drug Enforcement
The company plans to import the 1301.34(a), this is notice that on August Administration, that the requirements
listed controlled substance for the 9, 2007, Tocris Cookson, Inc., 16144 for such registration pursuant to 21
manufacture of a bulk controlled Westwoods Business Park, Ellisville, U.S.C. 958(a); 21 U.S.C. 823(a); and 21
substance for distribution to its Missouri 63021, made application by CFR 1301.34(b), (c), (d), (e), and (f) are
customer. renewal to the Drug Enforcement satisfied.

VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1